We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Osi Pharmaceuticals Inc. (MM) | NASDAQ:OSIP | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 57.49 | 0 | 01:00:00 |
From May 2019 to May 2024
Astellas Pharma Inc. (4503.TO) said Tuesday it has successfully completed its $4.0 billion tender offer for OSI Pharmaceuticals Inc. (OSIP), receiving offers for 93% of the U.S. cancer drug-developer's outstanding shares.
With over 90% of the shares offered, Astellas can complete the takeover without a meeting of OSI's shareholders, through a process known as a short-form merger.
OSI shares not tendered will be converted into rights to receive $57.50 per share, the company said. That was the price Astellas offered in its bid, which initially started as a hostile takeover attempt on March 2.
-By Kazuhiro Shimamura, Dow Jones Newswires; 813-6269-2790; kazuhiro.shimamura@dowjones.com
1 Year Osi Pharmaceuticals Chart |
1 Month Osi Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
